| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Barberich Timothy J serves as a Director at VSTM and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 0 sells. Those positions are worth an estimated $806K at current prices.
Historically, Barberich Timothy J's trades have earned a middling insider score of 56/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +7.9%.
The biggest single holding is VSTM (~$473K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 217,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | TCRX Tscan Therapeutics, Inc. | Director | Buy | 29,147 | $4.89 | $142,455.69 | +76.9% | +39.4% | -40.8% | |
| Jun 2, 2023 | TCRX Tscan Therapeutics, Inc. | Director | Buy | 37,880 | $2.63 | $99,563.79 | New | -15.3% | +204.3% | |
| Dec 4, 2020 | VSTM Verastem, Inc. | Director | Buy | 50,000 | $2.17 | $108,500.00 | +29.8% | - | - | |
| Mar 15, 2019 | VSTM Verastem, Inc. | Director | Buy | 33,000 | $3.21 | $105,930.00 | +24.4% | - | - | |
| Sep 28, 2018 | VSTM Verastem, Inc. | Director | Buy | 5,000 | $7.31 | $36,550.00 | +3.8% | - | - | |
| Dec 5, 2017 | VSTM Verastem, Inc. | Director | Buy | 60,538 | $3.95 | $239,125.10 | +87.2% | - | - | |
| May 15, 2017 | VSTM Verastem, Inc. | Director | Buy | 30,000 | $2.45 | $73,500.00 | +76.0% | - | - | |
| Jan 28, 2015 | VSTM Verastem, Inc. | Director | Buy | 38,462 | $6.50 | $250,003.00 | +3,846% | - | - |